An article in BioWorld Today, Oct. 18, 2010, should have stated that FerroKin Biosciences Inc.'s FBS0701 is a dose a day (rather than a single pill a day); a single dose might consist of up to five capsules. The article also should have clarified that the treatment is for transfusional iron overload only.

Editor's note: The correction has been made in BioWorld Online.

No Comments